TY - JOUR
T1 - Decreased nighttime heart rate variability and progression of white matter hyperintensities of presumed vascular origin. A prospective study in community-dwelling older adults
AU - Del Brutto, Oscar H.
AU - Mera, Robertino M.
AU - Costa, Aldo F.
AU - Rumbea, Denisse A.
AU - Recalde, Bettsy Y.
AU - Peñaherrera, Ernesto
AU - Del Brutto, Victor J.
N1 - Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/6
Y1 - 2022/6
N2 - Objectives: Evidence on the role of autonomic dysfunction on white matter hyperintensities (WMH) progression is limited. This study aims to assess the impact of a low nighttime heart rate variability (HRV) on WMH progression in community-dwelling older adults. Materials and methods: Following a prospective longitudinal study design, all individuals aged ≥60 years enrolled in the Atahualpa Project Cohort from 2012 to 2019 were invited to receive baseline HRV determinations through 24-h Holter monitoring, together with clinical interviews and brain MRIs. These individuals were periodically followed by means of annual door-to-door surveys, and those who also received brain MRIs at the end of the study (May 2021) were included in the analysis. Poisson regression models, adjusted for relevant confounders, were fitted to assess the incidence rate ratio (IRR) of WMH progression according to nighttime standard deviation of normal-to-normal R-R intervals (SDNN). Results: This study included 254 individuals aged ≥60 years (mean age: 65.4 ± 5.9 years; 55% women). The mean nighttime SDNN was 116.8 ± 36.3 ms. Follow-up MRIs showed WMH progression in 103 (41%) individuals after a median follow-up of 6.5 years. In unadjusted analyses, nighttime SDNN was lower among participants who developed WMH progression than in those who did not (p < 0.001). A Poisson regression model, adjusted for relevant covariates, disclosed a significantly inverse association between nighttime SDNN and WMH progression (IRR: 0.99; 95% C.I.: 0.98–0.99; p = 0.014). Conclusions: Study results show an inverse association between decreased nighttime SDNN and WMH progression, and provide support for the role of sympathetic overactivity in this relationship.
AB - Objectives: Evidence on the role of autonomic dysfunction on white matter hyperintensities (WMH) progression is limited. This study aims to assess the impact of a low nighttime heart rate variability (HRV) on WMH progression in community-dwelling older adults. Materials and methods: Following a prospective longitudinal study design, all individuals aged ≥60 years enrolled in the Atahualpa Project Cohort from 2012 to 2019 were invited to receive baseline HRV determinations through 24-h Holter monitoring, together with clinical interviews and brain MRIs. These individuals were periodically followed by means of annual door-to-door surveys, and those who also received brain MRIs at the end of the study (May 2021) were included in the analysis. Poisson regression models, adjusted for relevant confounders, were fitted to assess the incidence rate ratio (IRR) of WMH progression according to nighttime standard deviation of normal-to-normal R-R intervals (SDNN). Results: This study included 254 individuals aged ≥60 years (mean age: 65.4 ± 5.9 years; 55% women). The mean nighttime SDNN was 116.8 ± 36.3 ms. Follow-up MRIs showed WMH progression in 103 (41%) individuals after a median follow-up of 6.5 years. In unadjusted analyses, nighttime SDNN was lower among participants who developed WMH progression than in those who did not (p < 0.001). A Poisson regression model, adjusted for relevant covariates, disclosed a significantly inverse association between nighttime SDNN and WMH progression (IRR: 0.99; 95% C.I.: 0.98–0.99; p = 0.014). Conclusions: Study results show an inverse association between decreased nighttime SDNN and WMH progression, and provide support for the role of sympathetic overactivity in this relationship.
KW - Heart rate variability
KW - Progression
KW - Prospective cohort study
KW - Sympathetic activity
KW - White matter hyperintensities of presumed vascular origin
UR - http://www.scopus.com/inward/record.url?scp=85127923378&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127923378&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2022.106479
DO - 10.1016/j.jstrokecerebrovasdis.2022.106479
M3 - Article
AN - SCOPUS:85127923378
VL - 31
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
SN - 1052-3057
IS - 6
M1 - 106479
ER -